TP53 and lung adenocarcinoma: High BCAR1 expression was not correlated with poorer overall survival among breast cancer and lung adenocarcinoma patients with wild-type TP53. This suggests, at least in part, high BCAR1 expression itself is insufficient to drive breast cancer progression without the cooperation of mutant TP53.